Therefore, further investigation of co-targeting reciprocal interactions of AR and IGF1 pathways between epithelial tumor cells and surrounding tumor niches may provide insight into potential therapeutic strategies for treating advanced prostate cancer. This evidence concerns the gene IGF1 and neoplasm.